- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 24, 2026 | 203.07M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 206.06M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 219.83M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $1.45M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $1.15M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $49.77M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $74.06M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.99B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $3.03B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $32.54M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $36.76M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.86B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.07B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $3.27B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $3.31B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.36B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.47B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.35B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.66B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.06 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.11 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.11 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $13.95M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $12.26M |
| Net Income | Q1 2026 · Mar 31, 2026 | $11.39M |
| Net Income | Q1 2026 · Mar 31, 2025 | $23.73M |
| Revenue | Q1 2026 · Mar 31, 2026 | $200.7M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $221.08M |